A new research perspective was published in Oncotarget’s Volume 15 on February 5, 2024, entitled, “Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma.”
Exercise is good for health — but why? A study in rats offers insight
It’s widely known that exercise is beneficial for health. Yet science doesn’t have a clear understanding of what makes moving so good for us, including